David P. Meeker, President and CEO at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 86,966 shares at $65.04 ($5.7M) on 2025-06-03, disclosed to the SEC on 2025-06-05.
Scheduled sale ($5.7M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.04 | 43,346 | $2.8M | 49.8% |
| 2 | $65.04 | 43,346 | $2.8M | 49.8% |
| 3 | $65.60 | 274 | $18K | 0.3% |
| Total | $65.04 avg | 86,966 | $5.7M | 100% |
| Filing → |
| RYTM | SELL | 2025-02-04 | $508K | — | Filing → |
| TRVI | SELL | 2024-08-29 | $13K | — | Filing → |
| RYTM | SELL | 2024-03-19 | $3.6M | — | Filing → |